Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
23
pubmed:dateCreated
2009-6-9
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1526-632X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
9
pubmed:volume
72
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1972-3
pubmed:dateRevised
2010-3-5
pubmed:meshHeading
pubmed-meshheading:19439722-Adjuvants, Immunologic, pubmed-meshheading:19439722-Biological Markers, pubmed-meshheading:19439722-Central Nervous System, pubmed-meshheading:19439722-Disease Progression, pubmed-meshheading:19439722-Gadolinium, pubmed-meshheading:19439722-Humans, pubmed-meshheading:19439722-Injections, pubmed-meshheading:19439722-Interferon-beta, pubmed-meshheading:19439722-Magnetic Resonance Imaging, pubmed-meshheading:19439722-Multiple Sclerosis, pubmed-meshheading:19439722-Outcome Assessment (Health Care), pubmed-meshheading:19439722-Peptides, pubmed-meshheading:19439722-Predictive Value of Tests, pubmed-meshheading:19439722-Randomized Controlled Trials as Topic, pubmed-meshheading:19439722-Recurrence, pubmed-meshheading:19439722-Sensitivity and Specificity, pubmed-meshheading:19439722-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Seeing injectable MS therapies differently: they are more similar than different.
pubmed:publicationType
Editorial, Comment